Unfavourable Intermediate Risk Prostate Cancer
1 clinical trials · Condition
◉ Watch Unfavourable Intermediate Risk Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions (NCT07343349) | Rigshospitalet, Denmark | 2025-12-15 |
Track Unfavourable Intermediate Risk Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.